baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

INVISION AG/ DE0005859698 /

10/3/2023 5:36:28 PM	Chg. 0.000	Volume	Bid10/3/2023	Ask10/3/2023	Market Capitalization	Dividend Y.	P/E Ratio
7.400EUR	0.00%	0 Turnover: 0.000	-Bid Size: -	-Ask Size: -	16.99 mill.EUR	0.00%	-

GlobeNewswire 3/17/2022 Inivata and Collaborators Publish Clinical Validation Data for RaDaR™ Assay in Non-Small Cell Lung C...

GlobeNewswire 2/11/2022 Inivata and Collaborators Publish Positive Results from Prospective Clinical Study of RaDaR™ in Head...

GlobeNewswire 2/3/2022 ButcherJoseph Advises InVision on Sale to Its Employees

GlobeNewswire 1/11/2022 Inivata Announces RaDaR™ Assay Receives CE Mark and is Submitted for US Reimbursement via the MolDX ...

GlobeNewswire 11/23/2021 Loom Drives Millions of New Users, Significant Team Growth in 2021

GlobeNewswire 10/19/2021 Inivata Announces Clinical Collaboration with Princess Margaret Cancer Center for the use of its Liq...

GlobeNewswire 10/5/2021 Mike Kourey Joins Illumio’s Board of Directors

GlobeNewswire 9/9/2021 Inivata and collaborators to present data that further validate the application of its RaDaR™ MRD an...

GlobeNewswire 7/7/2021 SBA Hosts National SBIR Week to Connect Technology Innovators & Entrepreneurs with Research Funding

GlobeNewswire 5/25/2021 Inivata Announces Collaboration with F-star Therapeutics for the use of RaDaRTM Assay

GlobeNewswire 5/5/2021 Inivata to be Acquired by NeoGenomics

GlobeNewswire 4/28/2021 Inivata and Agendia Sign Agreement for Commercialization of RaDaR® MRD Liquid Biopsy Assay in Breast...

GlobeNewswire 4/10/2021 Inivata Presents New Data in Support of its Liquid Biopsy Technologies at AACR Virtual Annual Meetin...

GlobeNewswire 3/17/2021 Inivata to Present New Data in Support of its RaDaR™ MRD and InVisionFirst®-Lung tests at AACR Virtu...

GlobeNewswire 3/9/2021 FDA Grants Breakthrough Device Designation for Inivata’s RaDaR™ Assay

GlobeNewswire 2/4/2021 Inivata Raises $35 million in Second Close of Series C Financing

GlobeNewswire 1/20/2021 First Patients Tested with InVisionFirst®-Lung in EORTC Sponsored Phase II NSCLC Study

GlobeNewswire 1/7/2021 Logiq Appoints Tech Industry Veteran, Lea Hickman, to Board of Directors

GlobeNewswire 12/18/2020 Inivata’s Liquid Biopsy Technology Included in Unique £10m Research Collaboration for Early Detectio...

GlobeNewswire 11/16/2020 Inivata Appoints Dr. Alan Schafer as Chief Technology Officer

GlobeNewswire 11/5/2020 SurveyMonkey Announces Third Quarter 2020 Financial Results

GlobeNewswire 10/29/2020 Inivata Announces Collaboration with Maverick Therapeutics for use of RaDaR™ Assay

GlobeNewswire 9/22/2020 Inivata Appoints Peter Collins as Chief Business Officer

GlobeNewswire 9/16/2020 SurveyMonkey to Host Inaugural Customer Experience Summit

GlobeNewswire 7/15/2020 Crisp Raises $12M in Series A Funding from FirstMark to Match Food Supply with Fluctuating Demand

INVISION AG/ DE0005859698 /

If you wish to receive reply to your feedback, please provide your email address.